Canada markets closed

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
21.17-0.36 (-1.67%)
At close: 04:00PM EDT
21.73 +0.56 (+2.65%)
After hours: 07:26PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-481,192
-481,192
-474,186
-267,892
-134,231
Depreciation & amortization
8,976
8,976
7,572
6,891
6,311
Stock based compensation
134,050
134,050
91,400
47,009
19,903
Change in working capital
-52,452
-52,452
-53,873
-22,904
57,532
Accounts receivable
-32,688
-32,688
-1,737
99
2,490
Accounts Payable
2,522
2,522
-4,584
529
5,060
Other working capital
-408,071
-408,071
-391,677
-237,786
-53,497
Other non-cash items
6,724
6,724
80,880
2,937
-
Net cash provided by operating activites
-394,086
-394,086
-333,287
-225,030
-49,912
Cash flows from investing activities
Investments in property, plant and equipment
-13,985
-13,985
-58,390
-12,756
-3,585
Acquisitions, net
0
0
0
-3,000
0
Purchases of investments
-904,464
-904,464
-429,032
-1,020,620
-473,702
Sales/Maturities of investments
887,102
887,102
647,581
485,598
262,800
Net cash used for investing activites
-31,347
-31,347
160,309
-550,778
-214,487
Cash flows from financing activities
Common stock issued
119,795
119,795
565,789
693,570
358,648
Net cash used privided by (used for) financing activities
130,323
130,323
582,955
736,688
371,779
Net change in cash
-295,110
-295,110
409,977
-39,120
107,380
Cash at beginning of period
535,463
535,463
125,486
164,606
57,226
Cash at end of period
240,353
240,353
535,463
125,486
164,606
Free Cash Flow
Operating Cash Flow
-394,086
-394,086
-333,287
-225,030
-49,912
Capital Expenditure
-13,985
-13,985
-58,390
-12,756
-3,585
Free Cash Flow
-408,071
-408,071
-391,677
-237,786
-53,497